BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27576073)

  • 1. Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial.
    Nowalk MP; Lin CJ; Pavlik VN; Brown AE; Zhang S; Moehling KK; Raviotta JM; South-Paul JE; Hawk M; Ricci EM; Middleton DB; Patel SA; Ahmed F; Zimmerman RK
    Vaccine; 2016 Sep; 34(41):5026-5033. PubMed ID: 27576073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the 4 Pillars Practice Transformation Program to Increase Pneumococcal Immunizations for Older Adults: A Cluster-Randomized Trial.
    Zimmerman RK; Brown AE; Pavlik VN; Moehling KK; Raviotta JM; Lin CJ; Zhang S; Hawk M; Kyle S; Patel S; Ahmed F; Nowalk MP
    J Am Geriatr Soc; 2017 Jan; 65(1):114-122. PubMed ID: 27755655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
    Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial.
    Lin CJ; Nowalk MP; Pavlik VN; Brown AE; Zhang S; Raviotta JM; Moehling KK; Hawk M; Ricci EM; Middleton DB; Patel S; South-Paul JE; Zimmerman RK
    BMC Infect Dis; 2016 Nov; 16(1):623. PubMed ID: 27809793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program.
    Zimmerman RK; Moehling KK; Lin CJ; Zhang S; Raviotta JM; Reis EC; Humiston SG; Nowalk MP
    Vaccine; 2017 Jan; 35(1):109-117. PubMed ID: 27876200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old.
    Smith KJ; Nowalk MP; Lin CJ; Zimmerman RK
    Hum Vaccin Immunother; 2017 Oct; 13(10):2207-2212. PubMed ID: 28829719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a Mixed Methods Approach to Examine Practice Characteristics Associated With Implementation of an Adult Immunization Intervention Using the 4 Pillars Practice Transformation Program.
    Hawk M; Nowalk MP; Moehling KK; Pavlik V; Raviotta JM; Brown AE; Zimmerman RK; Ricci EM
    J Healthc Qual; 2017; 39(3):153-167. PubMed ID: 28166113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a multi-modal intervention on immunization rates in obstetrics and gynecology clinics.
    Mazzoni SE; Brewer SE; Pyrzanowski JL; Durfee MJ; Dickinson LM; Barnard JG; Dempsey AF; O'Leary ST
    Am J Obstet Gynecol; 2016 May; 214(5):617.e1-7. PubMed ID: 26627727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the 4 Pillars to increase vaccination among high-risk adults: who benefits?
    Nowalk MP; Moehling KK; Zhang S; Raviotta JM; Zimmerman RK; Lin CJ
    Am J Manag Care; 2017 Nov; 23(11):651-655. PubMed ID: 29182350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
    Pool V; Tomovici A; Johnson DR; Greenberg DP; Decker MD
    Vaccine; 2018 Apr; 36(17):2282-2287. PubMed ID: 29573876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis.
    Wateska AR; Nowalk MP; Zimmerman RK; Smith KJ; Lin CJ
    BMC Infect Dis; 2018 Jan; 18(1):52. PubMed ID: 29370768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of the 4 Pillars Practice Transformation Program to Improve Vaccination of Adults Aged 65 and Older.
    Smith KJ; Zimmerman RK; Nowalk MP; Lin CJ
    J Am Geriatr Soc; 2017 Apr; 65(4):763-768. PubMed ID: 28024090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.
    Mills B; Fensterheim L; Taitel M; Cannon A
    Vaccine; 2014 Jan; 32(4):521-5. PubMed ID: 24269619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center.
    Healy CM; Ng N; Taylor RS; Rench MA; Swaim LS
    Vaccine; 2015 Sep; 33(38):4983-7. PubMed ID: 26192356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season.
    Chamberlain AT; Seib K; Ault KA; Rosenberg ES; Frew PM; Cortés M; Whitney EA; Berkelman RL; Orenstein WA; Omer SB
    Vaccine; 2015 Jul; 33(30):3571-9. PubMed ID: 26044495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
    Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
    Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.